158 related articles for article (PubMed ID: 14672749)
1. In vivo evaluation of the novel calcineurin inhibitor ISATX247 in non-human primates.
Stalder M; Bîrsan T; Hubble RW; Paniagua RT; Morris RE
J Heart Lung Transplant; 2003 Dec; 22(12):1343-52. PubMed ID: 14672749
[TBL] [Abstract][Full Text] [Related]
2. The novel calcineurin inhibitor ISA247: a more potent immunosuppressant than cyclosporine in vitro.
Bîrsan T; Dambrin C; Freitag DG; Yatscoff RW; Morris RE
Transpl Int; 2005 May; 17(12):767-71. PubMed ID: 15827754
[TBL] [Abstract][Full Text] [Related]
3. ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
Drugs R D; 2007; 8(2):103-12. PubMed ID: 17324008
[TBL] [Abstract][Full Text] [Related]
4. Compared with cyclosporine, ISATX247 significantly prolongs renal-allograft survival in a nonhuman primate model.
Gregory CR; Kyles AE; Bernsteen L; Wagner GS; Tarantal AF; Christe KL; Brignolo L; Spinner A; Griffey SM; Paniagua RT; Hubble RW; Borie DC; Morris RE
Transplantation; 2004 Sep; 78(5):681-5. PubMed ID: 15371668
[TBL] [Abstract][Full Text] [Related]
5. In vivo pharmacokinetic and pharmacodynamic evaluation of the malononitrilamide FK778 in non-human primates.
Bîrsan T; Dambrin C; Klupp J; Stalder M; Larson MJ; Fitzsimmons WE; Morris RE
Transpl Int; 2003 May; 16(5):354-60. PubMed ID: 12712238
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of accelerated collagen induced arthritis by a novel calcineurin inhibitor, ISA(TX)247.
Maksymowych WP; Jhangri GS; Aspeslet L; Abel MD; Trepanier DJ; Naicker S; Freitag DG; Cooper BL; Foster RT; Yatscoff RW
J Rheumatol; 2002 Aug; 29(8):1646-52. PubMed ID: 12180723
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro.
Barten MJ; Gummert JF; van Gelder T; Shorthouse R; Morris RE
J Immunol Methods; 2001 Jul; 253(1-2):95-112. PubMed ID: 11384672
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine A affects the in vitro expression of T cell activation-related molecules and cytokines in dogs.
Fellman CL; Stokes JV; Archer TM; Pinchuk LM; Lunsford KV; Mackin AJ
Vet Immunol Immunopathol; 2011 Apr; 140(3-4):175-80. PubMed ID: 21227512
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive effects of surgery assessed by flow cytometry in nonhuman primates after nephrectomy.
Stalder M; Bîrsan T; Hausen B; Borie DC; Morris RE
Transpl Int; 2005 Oct; 18(10):1158-65. PubMed ID: 16162103
[TBL] [Abstract][Full Text] [Related]
10. [The effect of mycophenolic acid on activation antigen expression and in vitro T lymphocytes proliferation in peripheral blood].
Zheng W; Huang H; Xu C
Zhonghua Nei Ke Za Zhi; 2002 May; 41(5):329-32. PubMed ID: 12133428
[TBL] [Abstract][Full Text] [Related]
11. ISA(TX)247: a novel calcineurin inhibitor.
Aspeslet L; Freitag D; Trepanier D; Abel M; Naicker S; Kneteman N; Foster R; Yatscoff R
Transplant Proc; 2001; 33(1-2):1048-51. PubMed ID: 11267185
[No Abstract] [Full Text] [Related]
12. Cytokines and cell surface receptors as target end points of immunosuppression with cyclosporine A.
Sindhi R; Allaert J; Gladding D; Koppelman B; Dunne JF
J Interferon Cytokine Res; 2001 Jul; 21(7):507-14. PubMed ID: 11506745
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of re-expression of surface CD4, but not CD8, on activated human T-lymphocytes by the immunosuppressive drugs dexamethasone and cyclosporine A: correlation with inhibition of proliferation.
Haczku AF; Kay AB; Corrigan CJ
Int J Immunopharmacol; 1996 Jan; 18(1):45-51. PubMed ID: 8732432
[TBL] [Abstract][Full Text] [Related]
14. Effects of the malononitrilamide FK778 on immune functions in vitro in whole blood from non-human primates and healthy human volunteers.
Bîrsan T; Dambrin C; Klupp J; Stalder M; Fitzsimmons WE; Morris RE
Transpl Immunol; 2003; 11(2):163-7. PubMed ID: 12799199
[TBL] [Abstract][Full Text] [Related]
15. Effects of cyclosporine and dexamethasone on canine T cell expression of interleukin-2 and interferon-gamma.
Fellman CL; Archer TM; Wills RW; Mackin AJ
Vet Immunol Immunopathol; 2019 Oct; 216():109892. PubMed ID: 31446206
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of the effects of candidate immunosuppressive drugs: flow cytometry and quantitative real-time PCR as two independent and correlated read-outs.
Flores MG; Zhang S; Ha A; Holm B; Reitz BA; Morris RE; Borie DC
J Immunol Methods; 2004 Jun; 289(1-2):123-35. PubMed ID: 15251418
[TBL] [Abstract][Full Text] [Related]
17. Individual variability in cyclosporin A sensitivity: the assessment of functional measures on CD28-mediated costimulation of human whole blood T lymphocytes.
Härtel C; Hammers HJ; Schlenke P; Fricke L; Schumacher N; Kirchner H; Müller-Steinhardt M
J Interferon Cytokine Res; 2003 Feb; 23(2):91-9. PubMed ID: 12744774
[TBL] [Abstract][Full Text] [Related]
18. Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine.
Flechner SM; Goldfarb D; Modlin C; Feng J; Krishnamurthi V; Mastroianni B; Savas K; Cook DJ; Novick AC
Transplantation; 2002 Oct; 74(8):1070-6. PubMed ID: 12438948
[TBL] [Abstract][Full Text] [Related]
19. Preliminary in vivo pharmacokinetic and pharmacodynamic evaluation of a novel calcineurin-independent inhibitor of NFAT.
Bîrsan T; Dambrin C; Marsh KC; Jacobsen W; Djuric SW; Mollison KW; Christians U; Carter GW; Morris RE
Transpl Int; 2004 Mar; 17(3):145-50. PubMed ID: 14735234
[TBL] [Abstract][Full Text] [Related]
20. Effects of oral cyclosporine on canine T-cell expression of IL-2 and IFN-gamma across a 12-h dosing interval.
Fellman CL; Archer TM; Stokes JV; Wills RW; Lunsford KV; Mackin AJ
J Vet Pharmacol Ther; 2016 Jun; 39(3):237-44. PubMed ID: 26676223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
